Form D · Biotechnology

Cerebrotech Medical Systems, Inc.

Pleasanton, CA · CIK 0001525867

Offering snapshot reported Apr 26, 2017 · SEC filing

Reported sold
$3.09M
Offering amount: $6M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 12, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 26, 2017Initial$3,091,817No comparison19SEC filing
May 20, 2016Initial$3,468,006No comparison18SEC filing
Apr 8, 2013Amendment$1,749,981$250,001vs Jun 5, 201213SEC filing
Jun 5, 2012Initial$1,499,980No comparison12SEC filing
Jul 22, 2011Initial$680,000No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-285484
Actual total offering amount: $6,000,000.06; Actual total amount sold: $3,091,816.47

Source: Form D, filed Apr 26, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph C. Cook, Iii Director
Martin Dieck Director
Brian Laden Director
Mitchell Levinson Director, Executive
Issie Rabinovitch Director
Christopher Rand Director
Boris Rubinsky Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1048 Serpentine Lane Suite 301
Pleasanton, CA, 94566